You Don't Have a Contract Portfolio. You Have a Pile.

Nadia can tell you where every contract is, when it was signed, and when it expires. She’s one of the best at her job.

She's the contract administration manager. She keeps the repository, tracks the amendments, calendars the notice dates, and files the fee schedules when they finally show up. Ask her for the 2019 amendment that changed the implant carve-out and she'll have it on your desk before lunch. Nobody in that building knows the agreements better than she does.

In eleven years, nobody has asked her what they add up to.

That's worth thinking about. The person with the most complete view of the contract book has never once been asked to interpret it. She's only been asked to organize it and retrieve from it.

Most managed care departments run on a renewal queue. Something comes due, you work it, you sign it, it goes back in the repository, and you turn to the next one. That's a defensible way to operate. It's the way the work arrives, is prioritized, and departs.

But it means every decision gets made with exactly one contract in the room. You negotiate the renewal against that payer's history. You take the rate against that payer's benchmark. You measure the concession against what you gave that payer last cycle. Each conversation, judged on its own terms, looks reasonable.

But wait! Now ask a question that no single-contract conversation can answer. If your second-largest payer walked in January, what happens next?

Most systems can't answer that question readily. They can get there in about three weeks with a data request, a modeling exercise, and (at least) two meetings. Three weeks translates to a research project you commissioned after the question already cost you something.

The question of what happens next shows up more much often than it used to. Humana said on its July earnings call that it's exiting plans covering roughly eight percent (8%) of its Medicare Advantage membership for next year, with about 600,000 letters going out this month. Modern Healthcare reported in early August that UnitedHealthcare is weighing exits from 34 counties across a dozen states. On the exchange side, enhanced subsidies stayed dead, out-of-pocket premiums jumped about 58 percent (58%) for this plan year, and 51 insurers have asked for 2027 increases north of 25 percent (25%).

None of that is a rate problem. All of it is a portfolio composition problem. And your portfolio is invisible when viewed one contract at a time.

Ready for some tough love? The reason nobody can answer the what happens next question isn't that the data is missing. Nadia, decision support, finance and others have it in different formats. The stinging reason is that no one owns the aggregate. And that no one includes the contracting team.

Look at how the work is divided in almost every health system. Contracting owns agreements. Finance owns the budget. Revenue cycle owns collections. Strategy owns markets. The portfolio as a whole belongs to all of them, which is another way of saying it belongs to none of them. The questions only the whole portfolio can answer never get asked, because nobody's job description contains them.

So each of those critical department gets very good at the thing it's measured on, which is closing the next renewal, and stays blind to the thing nobody actually measures, which is what the closed renewals have quietly created over a decade.

I've run it the wrong way, too, so this isn't a lecture from the cheap seats. For a good stretch of my career I managed a queue and called it a strategy. I could have named our largest payer in a heartbeat. I could not have told you our concentration by segment, which quarters carried two significant scheduled renewals or terminations at once, or what a single exit would do to a specific service line. I found all of that out the way many people do; afterward.

The fix isn't a new system, a vendor, or a consulting engagement. Goodness knows we have enough of those already. Thankfully, the first version of a fix only requires an afternoon with data you already have and a spreadsheet you can create yourself.

Here's the columnar layout. Just five:

1. Revenue share by payer. Net revenue by payer for the trailing twelve months as a percentage of total. Sort it descending. Where do your top three land? Your top five? Write the numbers down, because from here on they're the denominator for everything else.

2. Revenue share by segment inside each payer. Commercial, Medicare Advantage, Managed Medicaid, exchange, and self-funded (where possible), broken out for each of your top payers. This is where you may be surprised. A payer that looks like a commercial relationship is frequently a Medicare Advantage relationship wearing a commercial mask.

3. Concentration by facility and service line. System-level concentration hides local dependence. A payer at nine percent (9%) of the enterprise volume can be forty percent (40%) of one hospital's outpatient surgical volume.

4. The renewal collision calendar. Every termination date, renewal date, and evergreen anniversary on one page, by quarter. You're looking for quarters that carry more than one significant agreement, because that's where your leverage and your attention both get divided while your team's capacity runs thin at the same time.

5. The walk number. For your top five, what's the revenue at risk if they exit? Then the harder second question. How much of that volume actually stays with you, finding its way back through another plan in the same market? Those two numbers are usually far apart. The gap between them is your real exposure, and almost nobody sits down to calculate it before a payer conflict is already underway.

If this is landing, connect with me and follow along, so the next one finds you: Kevin W. Barron, MBA, FHFMA, FACHE and Mastering Managed Care.

Now the interpretation, because the numbers alone will mislead you. The figure that matters isn't your concentration. It's the distance between your concentration and your leverage. A payer at twenty-two (22%) percent of net revenue where you're the only academic medical center in the market is a manageable position. A payer at twelve percent (12%) where three competitors offer the same service lines within twenty miles is a weaker position than the bigger number, and if you're ranking by revenue share alone you'll defend the wrong contract at exactly the wrong time.

Create that spreadsheet once and you'll never negotiate the same way again. You'll walk into the renewal knowing what that agreement is worth relative to everything else you hold, which is the only context in which the word "no" truly has meaning.

The cost of not having this spreadsheet and identifying its implications isn't theoretical, and it isn't valued in rate points.

(A) It's a board meeting where a Director asks what a plan's scheduled market exit does to the hospital and the answer being, "We're pulling that together."

(B) It's a service line making a sub-specialist recruitment decision on a payer mix that shifted two quarters ago.

(C) It's a contracting team spending its scarce concessions defending an agreement that mattered in 2025, while the agreement that will matter in 2028 renews quietly with a two percent escalator and nobody bothering to call Nadia for the details.

Six months from now, somebody asks the question in a hallway. What happens if that plan pulls out?

You, or Nadia, answers it in ninety seconds. She names the revenue, the segment split, the two facilities that carry the real exposure, the quarter it would land in, and the other agreement renewing that same quarter that would need to move first. No data request. No modeling exercise. No three weeks.

That's your portfolio. Everything before that was your pile.

Run the five-column review on your own portfolio this month, before the October letters start landing.

Consider the following: The contracts were never the asset. What they add up to is the asset, and until somebody does the math, you're managing a very well-organized pile just like I was.

About the Author

Kevin W. Barron, MBA, FHFMA, FACHE is a nationally recognized healthcare contracting and payer relations executive with over 30 years of experience in healthcare finance. He is an author, speaker, and mentor to emerging leaders in healthcare finance. Follow Kevin on LinkedIn or subscribe to his weekly newsletter at https://www.KevinWatsonBarron.com

Disclaimer: This article is provided for general informational and educational purposes only. It reflects my personal views and observations based on professional experience in healthcare finance, managed care, payer relations, and revenue cycle operations. It should not be interpreted as legal, financial, regulatory, actuarial, or reimbursement advice. The content is not intended to represent the official position of my employer, any payer, provider, professional association, or other organization with which I may be affiliated. Readers should consult their own legal, financial, compliance, actuarial, or operational advisors before making decisions based on the issues discussed. Any references to payers, providers, regulations, market trends, or reimbursement practices are intended for discussion and education only and should not be construed as a statement about any specific contract, negotiation, patient matter, or confidential business arrangement.